Markets
OSUR

OraSure Gets Approval For OraQuick HIV Self-Test For Use In Adolescents

January 07, 2025 — 07:48 am EST

Written by RTTNews.com for RTTNews->

(RTTNews) - OraSure Technologies, Inc. (OSUR) Tuesday announced expanded approval of its OraQuick HIV Self-Test to include individuals aged 14 years and older.

The test is already approved for people aged 17 and older.

According to the most recent data available from the Centers for Disease Control & Prevention, it is estimated that 19 percent of new HIV diagnoses in the United States were among young people aged 13 to 24, and only 6 percent of high school students have ever been tested for HIV.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

Markets
RTTNews
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.
More articles by this source->

Stocks mentioned

OSUR

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

  • •

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.